2025-08-29 16:46:56
Latest Post
Himadri Speciality Chemical Ltd Secures ISCC PLUS Certification
HCLSoftware delivers Digital Independence with AI-Powered Sovereign Collaboration Solutions for Business-Critical Infrastructure
Dr. Agarwal's Health Care Limited and Dr. Agarwal's Eye Hospital Limited announce Merger
SAMHI signs agreement to Lease for ~260-room Mid-Scale Hotel in Hyderabad's Financial District
Rail Vikas Nigam Ltd signs JV agreement with Texmaco Rail & Engineering Ltd
Stock Report
IPCA Laboratories Ltd posts consolidated PAT of Rs. 267.56 crores in Q3 FY2020-21
Posted On : 2021-02-04 13:28:26( TIMEZONE : IST )
IPCA LABORATORIES LTD. has reported financial results for the period ended December 31, 2020.
Financial Results (Q3 FY20-21) - QoQ Comparison
The company has reported total income of Rs.1425.21 crores during the period ended December 31, 2020 as compared to Rs.1376.55 crores during the period ended September 30, 2020.
The company has posted net profit / (loss) of Rs.267.56 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.266.70 crores for the period ended September 30, 2020.
The company has reported EPS of Rs.21.09 for the period ended December 31, 2020 as compared to Rs.21.08 for the period ended September 30, 2020.
| Financials | Q3 FY20-21 | Q2 FY20-21 | % Change |
| Total Income | ₹ 1425.21 crs | ₹ 1376.55 crs |  3.53% |
| Net Profit | ₹ 267.56 crs | ₹ 266.70 crs | 0.32% |
| EPS | ₹ 21.09 | ₹ 21.08 | 0.05% |
Financial Results (Q3 FY20-21) - YoY Comparison
The company has reported total income of Rs.1425.21 crores during the period ended December 31, 2020 as compared to Rs.1230.99 crores during the period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.267.56 crores for the period ended December 31, 2020 as against net profit / (loss) of Rs.197.54 crores for the period ended December 31, 2019.
The company has reported EPS of Rs.21.09 for the period ended December 31, 2020 as compared to Rs.15.63 for the period ended December 31, 2019.
| Financials | Q3 FY20-21 | Q3 FY19-20 | % Change |
| Total Income | ₹ 1425.21 crs | ₹ 1230.99 crs | 15.78% |
| Net Profit | ₹ 267.56 crs | ₹ 197.54 crs | 35.45% |
| EPS | ₹ 21.09 | ₹ 15.63 | 34.93% |
Financial Results (9 Months ended FY 20-21) - YoY Comparison
The company has reported total income of Rs.4348.25 crores during the 9 months period ended December 31, 2020 as compared to Rs.3628.22 crores during the 9 months period ended December 31, 2019.
The company has posted net profit / (loss) of Rs.979.94 crores for the 9 months period ended December 31, 2020 as against net profit / (loss) of Rs.520.51 crores for the 9 months period ended December 31, 2019.
The company has reported EPS of Rs.77.42 for the 9 months period ended December 31, 2020 as compared to Rs.41.18 for the 9 months period ended December 31, 2019.
| Financials | 9 Months ended FY20-21 | 9 Months ended FY19-20 | % Change |
| Total Income | ₹ 4348.25 crs | ₹ 3628.22 crs | 19.85% |
| Net Profit | ₹ 979.94 crs | ₹ 520.51 crs | 88.27% |
| EPS | ₹ 77.42 | ₹41.18 | 88% |
Shares of IPCA LABORATORIES LTD. was last trading in BSE at Rs.2037.95 as compared to the previous close of Rs. 1888.45. The total number of shares traded during the day was 32030 in over 3426 trades.
The stock hit an intraday high of Rs. 2051 and intraday low of 1898.45. The net turnover during the day was Rs. 63377876.
